RT @scipython3: Coming soon(-ish): Python for Chemists (CUP) https://t.co/ucF8Hlqep6
Articles to help early drug hunters on understanding drug likeness and lead optimization techniques. Girinath
Tuesday, 29 November 2022
Friday, 25 November 2022
Key Research Articles
RT @ProfFeynman: 17 Equations that changed the world. 🧠https://t.co/Ic9BWGcoKq
Key Research Articles
RT @pwk2013: #Atropisomerism is something that drug designers need to know about and here's an #OpenAccess review #isomerism #MedChem #SynChem #DrugDesign #OpenAccess https://t.co/DLljtFP6VK
Monday, 14 November 2022
Key Research Articles
RT @ErmanisKristaps: Only 2 weeks left to apply for a fully funded 42-month #PhDposition in my group! Focused on computational investigation of organic reactions and ML. https://t.co/OALpQ0eDVI Closes 30 November 2022. Please RT and get in touch if interested! #PhD #ChemJobs #compchem #chemtwitter
Friday, 11 November 2022
Key Research Articles

RT @ChemOrtuno: I have an open #compchem postdoc position to simulate ionic liquids with molecular dynamics. RT appreciated! Check link for details: https://t.co/9LWlgHJbIe
Wednesday, 9 November 2022
Key Research Articles

The Landscape of AI/ML in Drug Discovery | https://t.co/LnQJDGJRP1 The application of AI/ML methods to drug discovery has been an area of significant investment for at least 10 years now. This three-part Drug Hunter special on AI/ML in drug discovery summarizes the field. http https://t.co/8SZxU0SEtT
Thursday, 3 November 2022
Key Research Articles
What timing! Another great KRAS(G12C) example from Genentech just published today: https://t.co/Atn8hAR280 Source: drughuntersite
Monday, 24 October 2022
Key Research Articles

Thank You to Our Boston Event Sponsors | https://t.co/tgRTTVwCn9 Thanks to this week’s Boston event sponsors for helping make another great Drug Hunter mixer possible! We’ll be in the SF Bay Area, San Diego, Research Triangle, and the UK + EU soon - sign up to get notified https https://t.co/A22fhWG9nj
Tuesday, 18 October 2022
Key Research Articles

August 2022 #MoleculesOfTheMonth Runners-Up | https://t.co/fpNSM1oAbw You’ve seen Drug Hunter’s August Molecules of the Month; now read about five more that just missed out, featuring a drug for glioblastoma repurposed as a pan-apicomplexan antiparasitic agent, and more https:// https://t.co/LLgtPuJGlk
Wednesday, 12 October 2022
Key Research Articles

Drug Discovery Technology Review: Emerging Tools and Modalities in 2022Q2/Q3 | https://t.co/8fj0zL7jBb To keep you up to date on what’s happening in the biopharmaceutical industry, we’ve reviewed some of the most exciting updates from the past few months. #drughunter https://t https://t.co/ALs5xMPGxo
Friday, 7 October 2022
Key Research Articles

Billion-Dollar Molecules: Voxelotor, A $5.4 Billion Reversible Covalent Aldehyde | https://t.co/FEScFDVcyu Pfizer expands its presence in genetic diseases by acquiring voxelotor from Global Blood Therapeutics. Dive into the mechanism of action of the first-in-class drug and more https://t.co/vP7g4dTb5C
Tuesday, 4 October 2022
Key Research Articles
RT drughuntersite: ~~~~organic chemistry~~~~ https://t.co/xNgfygeVdw Source: drughuntersite https://t.co/4DEtooFcUB
Friday, 30 September 2022
Key Research Articles

August 2022 #MoleculesOfTheMonth | https://t.co/tIDCXd3z9i A covalent, proof-of-concept KRASG12R inhibitor, an oral dihydroorotate dehydrogenase inhibitor being developed for AML, and a first-in-class YAP-TEAD protein-protein are some examples of this month's MOTM. #drughunter https://t.co/xNaaDiYvjG
Subscribe to:
Posts (Atom)